Wood Tarver Financial Group, LLC Crispr Therapeutics Ag Transaction History
Wood Tarver Financial Group, LLC
- $299 Million
- Q4 2024
A detailed history of Wood Tarver Financial Group, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Wood Tarver Financial Group, LLC holds 775 shares of CRSP stock, worth $35,285. This represents 0.01% of its overall portfolio holdings.
Number of Shares
775Holding current value
$35,285% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$409 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$398 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$174 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$126 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$125 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.55B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....